Study #2021-0500
Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients with Mycosis Fungoides
MD Anderson Study Status
Enrolling
Treatment Agent
Brentuximab vedotin
Description
To learn if a form of radiation therapy (called ultra-low-dose - total skin electron beam therapy \[ULD-TSEBT\]) in combination with brentuximab vedotin can help to control mycosis fungoides
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Mycosis Fungoides
Study phase:
Phase II
Physician name:
Bouthaina Dabaja
Department:
Radiation Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.